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Fatigue is a ubiquitous symptom in every country so far studied, as
shown by high prevalences of fatigue in community and primary
care.1–6 Studies have also reported fatigue to be one of the most
frequent presenting complaints to doctors in primary care.7,8
However, clinical descriptions of chronic fatigue syndrome, also
known in some countries as myalgic encephalomyelitis, have
arisen from a limited number of high-income countries in
Northern Europe, North America and Oceania, which might indi-
cate sociocultural influences on the expression of the disorder.9,10
Alternatively, it has been suggested that the recognition of the dis-
order rather than the disorder itself is culturally influenced.11
However, to date, no direct comparison of the prevalence and/
or recognition of chronic fatigue syndrome across culturally and
economically distinct countries has been conducted. There are
very few epidemiological studies of chronic fatigue syndrome in
low- and middle-income countries,6 where both the population
and healthcare professionals seem unfamiliar with the construct
of the syndrome.12 Furthermore, the prevalence of the syndrome
varies widely according to the case definition, method and setting
adopted in each study, making comparisons of existing studies
unreliable. Indeed, the reported prevalence of chronic fatigue
syndrome ranges from 0.004% to 2.54% in the community,6,13–20
and from 0.11% to 2.6% in primary care.5,21–24 Our study
is a direct comparison of the prevalence and the physician
recognition of chronic fatigue syndrome in Brazilian and British
primary care using the same method. The prevalence of
unexplained chronic fatigue, a less severe ‘sub-syndromal’
counterpart of chronic fatigue syndrome, was also compared.
We hypothesised that the prevalence of unexplained chronic
fatigue and chronic fatigue syndrome measured using standard-
ised assessments would be similar in the two primary care settings,
but Brazilian general practitioners (GPs) would be less likely to
recognise and diagnose chronic fatigue syndrome than their
British colleagues.
Method
Study setting and participants
The study population consisted of consecutive primary care
attenders, aged 18–45 years. The age range was deliberately
restricted in an attempt to reduce the likelihood of misdiagnosing
medically explained fatigue as unexplained because medical
disorders that cause fatigue, for example anaemia, diabetes
mellitus and hypothyroidism, are much more prevalent in older
age groups.25 We deliberately chose to oversample Brazilian
patients compared with UK ones in a ratio of 2:1. There are
already several prevalence studies on unexplained chronic
fatigue/chronic fatigue syndrome in British primary care,23,26,27
but none in Brazil. Therefore, a reasonably large sample size was
required in Brazil to provide more accurate data on the prevalence
of both. Eleven general practices in Sa˜o Paulo and five in London
were selected.
In the UK, primary care is generally the first port of call for the
general population when they have a health problem, but Brazilian
primary care is more complex. According to the 2000 national
census, 24.5% of the Brazilian population are covered by at least
one type of health insurance and the rest dependent on public
healthcare. Hence, in order to obtain a study population
constituted by different socio-economic groups, reasonably
representative of the healthcare seeking population, ten public
clinics and one private clinic were selected across Sa˜o Paulo,
and 25.4% of the Brazilian sample was recruited from the
private clinic. In London, four practices were selected from
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Background
Although fatigue is a ubiquitous symptom across countries,
clinical descriptions of chronic fatigue syndrome have arisen
from a limited number of high-income countries. This might
reflect differences in true prevalence or clinical recognition
influenced by sociocultural factors.
Aims
To compare the prevalence, physician recognition and
diagnosis of chronic fatigue syndrome in London and Sa˜o
Paulo.
Method
Primary care patients in London (n=2459) and Sa˜o Paulo
(n=3914) were surveyed for the prevalence of chronic fatigue
syndrome. Medical records were reviewed for the physician
recognition and diagnosis.
Results
The prevalence of chronic fatigue syndrome according to
Centers for Disease Control 1994 criteria was comparable in
Britain and Brazil: 2.1% v. 1.6% (P=0.20). Medical records
review identified 11 diagnosed cases of chronic fatigue
syndrome in Britain, but none in Brazil (P50.001).
Conclusions
The primary care prevalence of chronic fatigue syndrome
was similar in two culturally and economically distinct
nations. However, doctors are unlikely to recognise and label
chronic fatigue syndrome as a discrete disorder in Brazil. The
recognition of this illness rather than the illness itself may be
culturally induced.
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inner-city areas and one from a suburban area. Additionally, to
maximise the comparability between the two countries, only the
public clinics with the Family Health Program, an official
programme which resembles the UK system, were recruited in
Brazil.
Assessments and procedures
Fatigue status including severity and duration was assessed with
the Chalder Fatigue Questionnaire (CFQ), an 11-item question-
naire widely used to measure physical and mental fatigue.28 Prior
to this study, we had conducted a rigorous process of translation,
back-translation, cross-cultural adaptation and validation of the
CFQ in Brazil, the details of which are provided elsewhere.29 Based
on the validation studies, we used a cut-off of 3/4 by bimodal
scoring for substantial fatigue in both countries.28,29 Chronic
fatigue was defined as a score of four or more on the CFQ with
a reported duration of 6 months or greater. Unexplained chronic
fatigue was defined as medically unexplained substantial fatigue
lasting 6 months or more according to the CFQ and the medical
examination. Chronic fatigue syndrome, characterised by severe
physical and mental fatigue and other accompanying symptoms
which cannot be explained by any other medical condition and
have persisted for at least 6 months, was assessed using the Centers
for Disease Control (CDC) 1994 case definition.30 We also
determined whether those participants who fulfilled criteria for
chronic fatigue had been diagnosed as a case of chronic fatigue
syndrome by their GPs. For this purpose, we reviewed their
medical records in search for the following diagnostic labels:
‘chronic fatigue’, ‘chronic fatigue syndrome’, ‘myalgic encephalo-
myelitis’ and ‘post-viral fatigue syndrome’. Finally, the 12-item
General Health Questionnaire (GHQ–12)31 was used with the
conventional cut-off of 3/4 by bimodal scoring to determine
probable common mental disorder, as validated in both British31
and Brazilian primary care.32 Ethical approval was obtained from
the research ethics committees of King’s College Hospital,
Institute of Psychiatry, London, UK, and the Municipal Depart-
ment of Health of Sa˜o Paulo and University of Sa˜o Paulo Medical
School, Brazil.
Phase 1 (screening)
Consecutive attenders at the general practices were invited to
participate in the study while they were waiting for their
appointment. After reading an information leaflet and signing a
consent form, individuals completed the CFQ and the GHQ–12.
The questionnaires were read out to illiterate and functionally
illiterate participants.
Phase 2
Those who fulfilled criteria for chronic fatigue were then asked to
complete a questionnaire on the CDC–1994 case definition of
chronic fatigue syndrome.30 Their medical records were reviewed
to determine whether they had medical and/or psychiatric exclu-
sionary conditions for the syndrome according to the CDC–1994
case definition, and whether their GPs had diagnosed them as
chronic fatigue syndrome cases. The medical records review took
place approximately 4 months after the completion of the ques-
tionnaire to enable the necessary investigations to be processed.
In addition to those investigations requested by the treating doc-
tor, we performed some routine laboratory investigations (liver
and thyroid function, full blood count, creatinine and glycosilated
haemoglobin) in all Brazilian participants with chronic fatigue
because, in Brazil, we expected medical exclusion diagnoses to
be more frequent and these investigations were less likely to be
requested by the examining doctor. Those individuals with chronic
fatigue with neither medical nor psychiatric exclusionary diagnoses
for chronic fatigue syndrome were classified as having unexplained
chronic fatigue, which therefore corresponds closely to the general
concept of medically unexplained symptoms.
Analysis
Stata Version 10 for Windows33 was employed for all statistical
analyses and the significance level was set at P=0.05. Participant
characteristics were compared between the two countries by
two-tailed chi-squared or t-tests. The prevalence of unexplained
chronic fatigue and chronic fatigue syndrome in each country
was estimated with the appropriate 95% confidence interval
(CI). The aforementioned diagnostic labels were counted during
the medical records review, and the percentage frequency in each
country with 95% CI was calculated as a proxy for the physician
recognition rate of the syndrome. The prevalence of each fatigue
category – unexplained chronic fatigue, chronic fatigue syndrome
and diagnostic labels – was compared between Brazil and the UK
using a chi-squared test. Furthermore, in order to take into
account the confounding effect of socio-demographic charac-
teristics and common mental disorder, multivariable logistic
regression was conducted with country membership (Brazil v.
UK) as the exposure variable and each fatigue category as the
outcome variable.
Results
Valid screening questionnaires were obtained from 3921 parti-
cipants in Sa˜o Paulo and 2530 in London (Fig. 1). Seven
questionnaires had missing data in Brazil and 71 in the UK.
Therefore, 3914 participants were considered for data analysis in
Brazil and 2459 in the UK. In Brazil, 1542 (39.4%) had a score
above the cut-off of the CFQ, which corresponds to substantial
fatigue, and 609 (15.6%) were individuals with chronic fatigue.
In the UK, 1046 (42.5%) had a score above the cut-off and
305 (12.4%) were individuals with chronic fatigue. All socio-
demographic characteristics except age were significantly different
between the two samples (Table 1). Brazilian participants had a
lower education level, and were more likely to be female, to have
a stable partner (i.e. married or cohabiting), to have a manual
occupation and to be unemployed. Although Brazilian and British
participants reported similar fatigue levels, the former group
appeared more psychologically distressed as shown by a higher
prevalence of common mental disorder (Table 1).
Of the 609 Brazilian and 305 British participants with chronic
fatigue, 133 (21.8%) and 52 (17.1%) respectively had a medical or
psychiatric exclusionary condition and were classified as individ-
uals with explained chronic fatigue. Consequently, the prevalence
of unexplained chronic fatigue was 12.2% (95% CI 11.2–13.2) in
Brazil and 10.3% (95% CI 9.1–11.6) in the UK (Table 2). Thirty-
six of 609 Brazilian participants with chronic fatigue (5.9%) and
99 of 305 British ones (32.5%) did not supply adequate
information for the diagnosis of chronic fatigue syndrome, and
they scored slightly lower on the CFQ compared with those who
supplied adequate information (P=0.05 in both countries). The
prevalence of chronic fatigue syndrome was therefore adjusted
for non-response, using non-responders’ CFQ score as the
predictor of their chronic fatigue syndrome caseness in logistic
regression. The estimated prevalence of the syndrome according
to the CDC–1994 criteria was 1.6% (95% CI 1.3–2.1) in Brazil
and 2.1% (95% CI 1.5–2.7) in the UK. When controlled for
socio-demographic characteristics (age, gender, education, marital
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Table 1 Participant characteristics compared between Brazil (n=3914) and the UK (n=2459) by chi-squared or t-tests
Variable Brazil UK P
Age, years: mean (s.d.) 31.7 (7.9) 31.6 (7.2) 0.56
Female, n (%) 3120 (79.7) 1759 (71.5) 50.001
Education, years: mean (s.d.) 8.7 (4.4) 15.3 (4.5) 50.001
Marital status, n (%) 50.001
Married or cohabiting 2188 (55.9) 1304 (53.0)
Single 1366 (34.9) 986 (40.1)
Separated, divorced or widowed 360 (9.2) 169 (6.9)
Employment status, n (%) 50.001
Employed 2645 (67.6) 1683 (68.4)
Student 206 (5.3) 200 (8.1)
Homemaker 535 (13.7) 316 (12.9)
Unemployed 444 (11.3) 159 (6.5)
On sick leave 84 (2.1) 101 (4.1)
Occupation, n (%) 50.001
Non-manual 1519 (38.8) 1495 (62.1)
Manual 2092 (53.4) 585 (24.3)
Student or never worked 105 (2.7) 185 (7.7)
Homemaker 198 (5.1) 143 (5.9)
Common mental disorder, n (%) 1703 (43.5) 913 (37.1) 50.001
Fatigue,a mean (s.d.) 3.3 (3.2) 3.4 (3.4) 0.20
a. Total score of the Chalder Fatigue Questionnaire using bimodal scoring system.
Table 2 Prevalence of unexplained chronic fatigue, chronic fatigue syndrome and diagnostic labels related to chronic fatigue
syndromea compared between Brazil and the UK by logistic regression
Brazil UK
Unadjusted Adjusted
Fatigue category
Total
screenedb
Prevalence
n (%)
Total
screenedb
Prevalence
n (%)
ORc
(95% CI) P
ORd
(95% CI) P
Unexplained chronic fatigue 3914 476 (12.2) 2459 253 (10.3) 0.83 (0.70–0.97) 0.02 0.92 (0.74–1.13) 0.42
Chronic fatigue syndrome 3914 64 (1.6) 2459 51 (2.1) 1.27 (0.88–1.85) 0.20 1.52 (0.94–2.44) 0.09
Diagnostic labels 391 0 269 11 (4.1) Not applicable 50.001e Not applicable 50.001e
a. Diagnostic labels related to chronic fatigue syndrome included ‘chronic fatigue’, ‘chronic fatigue syndrome’, ‘myalgic encephalomyelitis’ and ‘post-viral fatigue syndrome’.
b. For diagnostic labels, total is the number of medical notes reviewed.
c. Odds ratio calculated with Brazil as the reference category.
d. Adjusted for age, gender, education, marital status, employment status, occupation and common mental disorder.
e. P for chi-squared test.
Screening
n=3921
Complete screening data
n=3914
Chronic fatigue
n=609
Unexplained chronic fatigue
n=476
Screening
n=2530
Complete screening data
n=2459
Chronic fatigue
n=305
Unexplained chronic fatigue
n=253
Missing data
n=7
Non-chronic fatigue
n=3305
Explained chronic fatigue
n=133
Missing data
n=71
Non-chronic fatigue
n=2154
Explained chronic fatigue
n=52
Brazil UK
8
8
8
8
8
8
6
6
6
6
6
6
Fig. 1 Flow chart of the study.
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status, employment status and occupation) and common mental
disorder using multivariate logistic regression, the differences in
the prevalence of unexplained chronic fatigue and chronic fatigue
syndrome between the two groups were not statistically significant
(Table 2).
In Brazil, of 609 individuals with chronic fatigue, we could
only locate medical records for 391. Those for whom we could
not locate medical records were less educated (P50.001) and
more likely to have a manual occupation (P50.001), whereas
all the other characteristics including fatigue level were similar.
None of the 391 medical records reviewed (0%, 95% CI 0–0.9)
had any mention of chronic fatigue, chronic fatigue syndrome,
myalgic encephalomyelitis or post-viral fatigue syndrome (Table
2). In the UK, we located medical records for 269 out of 305
individuals with chronic fatigue and 11 of the medical records
reviewed (4.1%, 95% CI 2.1–7.2) contained such a diagnosis
(w2=16.26, d.f.=1, P50.001). No logistic regression was conducted
for this fatigue category due to a zero cell.
Discussion
Unexplained chronic fatigue was a common symptom with a
comparable prevalence in both Brazilian and British primary care
settings. As expected, chronic fatigue syndrome was less common
than unexplained chronic fatigue, but prevalence was similar in
both settings. Although both unexplained chronic fatigue and
chronic fatigue syndrome were therefore similarly common in
the two countries, Brazilian GPs were unlikely to recognise or
diagnose chronic fatigue syndrome unlike their British colleagues,
in accordance with the study hypothesis.
Prevalence of unexplained chronic fatigue and
chronic fatigue syndrome
Our study used a design similar to those of previous British
primary care studies, and the prevalence of unexplained chronic
fatigue (12.2% in Brazil and 10.3% in Britain) was roughly similar
to previous estimates (11.2% by McDonald et al26 and 11.3% by
Wessely et al23). Chronic fatigue syndrome was also comparably
prevalent (1.6% in Brazil and 2.1% in Britain) to previous UK
and USA estimates (2.6% by Wessely et al23 and 2.5% by Reeves
et al20). In the same way as fatigue is a universal symptom occur-
ring across regions and cultures, chronic fatigue syndrome as
defined by the current international consensus was also similar
between Brazil and the UK. Furthermore, unexplained chronic
fatigue as a less severe sub-syndromal counterpart of chronic
fatigue syndrome was similarly common across the two countries,
consistent with the notion that fatigue is distributed as a continuous
variable in the general population.2,28
Recognition and labelling of fatigue
Terms such as chronic fatigue syndrome, myalgic encephalomyeli-
tis and post-viral fatigue syndrome are routinely made diagnoses
in British primary care as shown by the analysis of the UKGeneral
Practice Research Database.33 However, two vignette studies from
Brazil showed that even university-based tertiary care doctors are
unfamiliar with the construct of chronic fatigue syndrome and
rarely diagnose it in their medical practice.12,34 Our study
confirmed this observation using actual case notes. Although the
prevalence of the syndrome in Brazil as assessed using a standard-
ised procedure is comparable to that in the UK, it is not a
diagnostic concept currently used in Brazilian medical practice
and is neither recognised nor diagnosed.
Fatigue as a symptom elicited by a questionnaire or recorded
by an interviewer should mostly reflect the presence or absence of
the symptom in an individual. However, fatigue as a diagnosis
made by the physician depends upon factors other than the simple
presence or absence of the symptom. Much needs to happen for
GPs to recognise fatigue cases and label them with such diagnoses
as chronic fatigue syndrome, myalgic encephalomyelitis and post-
viral fatigue syndrome. First of all, the doctor needs to attribute
some importance to the symptom of fatigue. It has been shown
that doctors accord fatigue only a minor importance in com-
parison with patients – doctors rate it as far less important than
patients, probably because of its ubiquity and lack of diagnostic
specificity.35 Furthermore, the practitioner needs to be aware of
these labels and to have at least some knowledge of the diagnostic
concept. Even then, a practitioner may be well aware of the
concepts and/or labels, but feel that these are not valid or useful,
and hence not use them. Studies of doctors’ knowledge and
attitudes towards chronic fatigue syndrome/myalgic encephalo-
myelitis have indicated that opinions vary widely about the
existence and utility of these labels.36,37 There are also changes
in physicians’ diagnostic patterns for fatigue over time.33
These factors, upon which the recognition and labelling of
fatigue depend, may have an important link with the sociocultural
setting. The degree of medicalisation of the population and
awareness of chronic fatigue syndrome among the population
and the medical professionals may be important. The explanatory
models held by individuals with chronic fatigue seem to be more
biomedically oriented in Western affluent societies compared with
non-Western societies.38–40 Further data from the current study,
reported elsewhere,41 demonstrated that British people with
unexplained chronic fatigue were more likely to attribute their
fatigue to physical causes than their Brazilian counterparts in line
with this proposition. Moreover, while chronic fatigue syndrome
is well known and officially endorsed as a medical condition in
the UK,42 it is little known in Brazil by either patients or
doctors.12,34 We believe that these differences in sociocultural
context between Brazil and the UK have contributed to the current
findings. Conversely, these findings indicate the importance of
sociocultural factors not so much in the occurrence and distrib-
ution of fatigue but more in the recognition and labelling of
fatigue. In Brazil, where unexplained fatigue is not sanctioned as
a medical condition worthy of medical treatment, sick leave or
sickness benefit,12,34 it may be more likely to be considered as part
of everyday adversity and less likely to be recognised as a medical
disorder. Likewise, individuals with a similar range of symptoms
are considerably less likely to receive a label of chronic fatigue
syndrome/myalgic encephalomyelitis in Brazil than in the UK.
Limitations and strengths
The study has some limitations. First, the medical records review
for the assessment of fatigue diagnosis was incomplete in Brazil –
medical records could not be traced for almost 30% of Brazilian
participants with chronic fatigue. In addition, although the UK
medical records were all electronic and mostly complete, the
available Brazilian medical records were all on paper and
frequently lacking information on examination results. None the
less, the absence of any fatigue diagnosis in a far larger pool of
medical records in Brazil is unlikely to be explained by this
limitation. In addition, the type of quality problem observed in
the Brazilian medical records was not directly related to diagnostic
labels and we conducted laboratory tests in Brazil to compensate
for this particular deficiency. Furthermore, as mentioned above,
there is also evidence that Brazilian doctors are unfamiliar with
the construct of chronic fatigue syndrome and rarely use this
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diagnosis in their practice.12,34 Second, general practices were not
randomly selected and consequently selection bias was possible. In
order to minimise this problem, we employed the sampling
strategy of including different social classes in proportion to the
national data and selecting general practices with similar
characteristics in the two countries.
Despite these limitations, this study also had some strengths as
it included large samples with a reasonable number of clinics;
made a direct comparison of a poorly explored topic in two
culturally and economically distinct settings using the same
method; employed cross-culturally validated measures of
fatigue and psychological distress; and conducted multivariable
analyses.
This is the first study to specifically estimate the prevalence of
unexplained chronic fatigue/chronic fatigue syndrome in Brazil. If
taken at face value, it raises the question of unexplained chronic
fatigue/chronic fatigue syndrome as a hidden public health issue
in Brazil given the prevalence of and the disability caused by the
conditions. More importantly, this is the first study to examine
the epidemiology of chronic fatigue syndrome using the same
standardised methodology across two culturally and
economically distinct countries, an Anglophone affluent country
and a Latin American middle-income country. Despite its limita-
tions, this study provides some evidence about the role of socio-
cultural factors in the recognition of fatigue and the use of
labels such as chronic fatigue syndrome/myalgic encephalomyeli-
tis. In other words, the recognition of this illness rather than the
illness itself seems to be culturally induced. The overall conclusion
is that unexplained chronic fatigue/chronic fatigue syndrome can
be found in Brazil in similar proportions as the UK, if one cares to
look. At the moment, it seems that Brazilian society, or more
specifically its healthcare system, does not care to look. How
appropriate that is, and what the impact is, will remain a matter
of speculation. Further research on the pragmatic implications
of the current findings may shed more light on the understanding
of this controversial, continuing but real health problem.
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Reading works of fiction and attending to the language, the dialogue, the mood is like listening to patients. In both activities, we enter into
other worlds, grasp something about the inner life of characters whose motivations may be unlike our own. D. H. Lawrence referring to this
aspect of the novel wrote: ‘It can inform and lead into new places the flow of our sympathetic consciousness, and it can lead our sympathy
away in recoil from things gone dead. Therefore the novel, properly handled, can reveal the most secret places of life’. Is this not also, partly,
the task of psychiatry?
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